AdvanCell is an Australian radiopharmaceutical firm in the clinical stages that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment.

Clinical Trials

Pharmaceutical

Biotechnology

AdvanCell Isotopes Pty Ltd

Andrew Adamovich

Anna Karmann

Simon Puttick

Aaron Pickett

Paola Santoro

Gary Li

The Research and Development team at AdvanCell Isotopes Pty Ltd focuses on advancing the Targeted Alpha Therapy platform for cancer treatment. This team collaborates to innovate and enhance radiopharmaceuticals through rigorous scientific research, development of new materials, and ensuring ethical and safety compliance in preclinical studies.

Research and Development

The Leadership Team at AdvanCell Isotopes Pty Ltd guides the company's strategic direction, oversees the development and commercialization of their Targeted Alpha Therapy platform technology, ensures robust financial health, and fosters innovation in nuclear and chemical sciences to advance cutting-edge cancer treatments.

Leadership Team

AdvanCell Isotopes Pty Ltd

Org chart

Teams

Research and Development

Leadership Team

Offices

AdvanCell Isotopes Pty Ltd

Org chart

Teams

Research and Development

Leadership Team

Offices

Related companies